Identification of Mycobacterium fortuitum and Mycobacterium chelonei. 1983

V Lévy-Frébault, and M Daffé, and K S Goh, and M A Lanéelle, and C Asselineau, and H L David

The study of 52 strains of rapidly growing mycobacteria showed that Mycobacterium fortuitum and M. chelonei were clearly distinguished by the aid of seven key tests (nitrate reductase, iron uptake, beta-glucosidase, penicillinase, growth on fructose, resistance to pipemidic acid, and resistance to capreomycin) and by analysis of their respective mycolic acids. However, the subdivision of these species into M. fortuitum var. fortuitum and M. fortuitum var. peregrinum and M. chelonei subsp. chelonei and M. chelonei subsp. abscessus was not satisfactorily accomplished.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D009171 Mycolic Acids Long fatty acids found in the CELL WALLS of some ACTINOBACTERIA, including MYCOBACTERIUM TUBERCULOSIS. Mycolic Acid,Acid, Mycolic,Acids, Mycolic
D009565 Nitrate Reductases Oxidoreductases that are specific for the reduction of NITRATES. Reductases, Nitrate
D010876 Pipemidic Acid Antimicrobial against Gram negative and some Gram positive bacteria. It is protein bound and concentrated in bile and urine and used for gastrointestinal, biliary, and urinary infections. Piperamic Acid,Deblaston,Galusan,Nuril,Palin,Pipram,Urisan,Uropipemid,Acid, Pipemidic,Acid, Piperamic
D002207 Capreomycin Cyclic peptide antibiotic similar to VIOMYCIN. It is produced by Streptomyces capreolus. Capreomycin Sulfate,Capastat,Capromycin
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D005632 Fructose A monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding. Levulose,Apir Levulosa,Fleboplast Levulosa,Levulosa,Levulosa Baxter,Levulosa Braun,Levulosa Grifols,Levulosa Ibys,Levulosa Ife,Levulosa Mein,Levulosado Bieffe Medit,Levulosado Braun,Levulosado Vitulia,Plast Apyr Levulosa Mein,Levulosa, Apir,Levulosa, Fleboplast
D006867 Hydrolases Any member of the class of enzymes that catalyze the cleavage of the substrate and the addition of water to the resulting molecules, e.g., ESTERASES, glycosidases (GLYCOSIDE HYDROLASES), lipases, NUCLEOTIDASES, peptidases (PEPTIDE HYDROLASES), and phosphatases (PHOSPHORIC MONOESTER HYDROLASES). EC 3. Hydrolase

Related Publications

V Lévy-Frébault, and M Daffé, and K S Goh, and M A Lanéelle, and C Asselineau, and H L David
January 1981, Journal of clinical microbiology,
V Lévy-Frébault, and M Daffé, and K S Goh, and M A Lanéelle, and C Asselineau, and H L David
January 1981, Reviews of infectious diseases,
V Lévy-Frébault, and M Daffé, and K S Goh, and M A Lanéelle, and C Asselineau, and H L David
July 1985, Infection control : IC,
V Lévy-Frébault, and M Daffé, and K S Goh, and M A Lanéelle, and C Asselineau, and H L David
September 1982, Tubercle,
V Lévy-Frébault, and M Daffé, and K S Goh, and M A Lanéelle, and C Asselineau, and H L David
March 1978, The Journal of infectious diseases,
V Lévy-Frébault, and M Daffé, and K S Goh, and M A Lanéelle, and C Asselineau, and H L David
February 1985, Antimicrobial agents and chemotherapy,
V Lévy-Frébault, and M Daffé, and K S Goh, and M A Lanéelle, and C Asselineau, and H L David
June 1982, Tubercle,
V Lévy-Frébault, and M Daffé, and K S Goh, and M A Lanéelle, and C Asselineau, and H L David
December 1978, Tubercle,
V Lévy-Frébault, and M Daffé, and K S Goh, and M A Lanéelle, and C Asselineau, and H L David
August 1986, European journal of clinical microbiology,
V Lévy-Frébault, and M Daffé, and K S Goh, and M A Lanéelle, and C Asselineau, and H L David
March 1978, The American review of respiratory disease,
Copied contents to your clipboard!